» Articles » PMID: 23345421

Mesothelial Cells Give Rise to Hepatic Stellate Cells and Myofibroblasts Via Mesothelial-mesenchymal Transition in Liver Injury

Overview
Specialty Science
Date 2013 Jan 25
PMID 23345421
Citations 112
Authors
Affiliations
Soon will be listed here.
Abstract

In many organs, myofibroblasts play a major role in the scarring process in response to injury. In liver fibrogenesis, hepatic stellate cells (HSCs) are thought to transdifferentiate into myofibroblasts, but the origins of both HSCs and myofibroblasts remain elusive. In the developing liver, lung, and intestine, mesothelial cells (MCs) differentiate into specific mesenchymal cell types; however, the contribution of this differentiation to organ injury is unknown. In the present study, using mouse models, conditional cell lineage analysis has demonstrated that MCs expressing Wilms tumor 1 give rise to HSCs and myofibroblasts during liver fibrogenesis. Primary MCs, isolated from adult mouse liver using antibodies against glycoprotein M6a, undergo myofibroblastic transdifferentiation. Antagonism of TGF-β signaling suppresses transition of MCs to mesenchymal cells both in vitro and in vivo. These results indicate that MCs undergo mesothelial-mesenchymal transition and participate in liver injury via differentiation to HSCs and myofibroblasts.

Citing Articles

Periductal fibroblasts participate in liver homeostasis, fibrosis, and tumorigenesis.

Wang S, Yuan J, Tang X, Yin X, Fang K, Chen L J Exp Med. 2025; 222(4).

PMID: 39888328 PMC: 11784584. DOI: 10.1084/jem.20232123.


Single-cell transcriptomic reveals the peritoneal microenvironmental change in long-term peritoneal dialysis patients with ultrafiltration failure.

Diao X, Zhan C, Ye H, Wu H, Yi C, Lin J iScience. 2024; 27(12):111383.

PMID: 39687014 PMC: 11647153. DOI: 10.1016/j.isci.2024.111383.


Targeting Fibrosis: From Molecular Mechanisms to Advanced Therapies.

Di X, Li Y, Wei J, Li T, Liao B Adv Sci (Weinh). 2024; 12(3):e2410416.

PMID: 39665319 PMC: 11744640. DOI: 10.1002/advs.202410416.


Store-Operated Ca Entry in Fibrosis and Tissue Remodeling.

Abdelnaby A, Trebak M Contact (Thousand Oaks). 2024; 7:25152564241291374.

PMID: 39659877 PMC: 11629433. DOI: 10.1177/25152564241291374.


Reversing the path: Mesenchymal-to-mesothelial transition as a novel target in liver fibrosis.

Gao Y Mol Ther. 2024; 32(9):2808-2809.

PMID: 39178852 PMC: 11403214. DOI: 10.1016/j.ymthe.2024.08.006.


References
1.
Higashiyama R, Moro T, Nakao S, Mikami K, Fukumitsu H, Ueda Y . Negligible contribution of bone marrow-derived cells to collagen production during hepatic fibrogenesis in mice. Gastroenterology. 2009; 137(4):1459-66.e1. DOI: 10.1053/j.gastro.2009.07.006. View

2.
Friedman S . Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev. 2008; 88(1):125-72. PMC: 2888531. DOI: 10.1152/physrev.00013.2007. View

3.
Bochmann L, Sarathchandra P, Mori F, Lara-Pezzi E, Lazzaro D, Rosenthal N . Revealing new mouse epicardial cell markers through transcriptomics. PLoS One. 2010; 5(6):e11429. PMC: 2893200. DOI: 10.1371/journal.pone.0011429. View

4.
Xu J, Lamouille S, Derynck R . TGF-beta-induced epithelial to mesenchymal transition. Cell Res. 2009; 19(2):156-72. PMC: 4720263. DOI: 10.1038/cr.2009.5. View

5.
Asahina K, Zhou B, Pu W, Tsukamoto H . Septum transversum-derived mesothelium gives rise to hepatic stellate cells and perivascular mesenchymal cells in developing mouse liver. Hepatology. 2011; 53(3):983-95. PMC: 3078645. DOI: 10.1002/hep.24119. View